Harnessing the endogenous Type I-C CRISPR-Cas system for genome editing in Bifidobacterium breve
dc.check.date | 06/08/2024 | en |
dc.check.info | Access to this article is restricted until 6 months after publication by request of the publisher | en |
dc.contributor.author | Han, Xiao | en |
dc.contributor.author | Chang, Lulu | en |
dc.contributor.author | Chen, Haiqin | en |
dc.contributor.author | Zhao, Jianxin | en |
dc.contributor.author | Tian, Fengwei | en |
dc.contributor.author | Ross, R. Paul | en |
dc.contributor.author | Stanton, Catherine | en |
dc.contributor.author | van Sinderen, Douwe | en |
dc.contributor.author | Chen, Wei | en |
dc.contributor.author | Yang, Bo | en |
dc.contributor.editor | Dudley, Edward G. | en |
dc.contributor.funder | National Key Research and Development Program of China | en |
dc.contributor.funder | National Natural Science Foundation of China | en |
dc.contributor.funder | Project 211 | en |
dc.contributor.funder | Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province | en |
dc.date.accessioned | 2024-04-18T14:24:51Z | |
dc.date.available | 2024-04-18T14:24:51Z | |
dc.date.issued | 2024-02-06 | en |
dc.description.abstract | Bifidobacterium breve, one of the main bifidobacterial species colonizing the human gastrointestinal tract in early life, has received extensive attention for its purported beneficial effects on human health. However, exploration of the mode of action of such beneficial effects exerted by B. breve is cumbersome due to the lack of effective genetic tools, which limits its synthetic biology application. The widespread presence of CRISPR-Cas systems in the B. breve genome makes endogenous CRISPR-based gene editing toolkits a promising tool. This study revealed that Type I-C CRISPR-Cas systems in B. breve can be divided into two groups based on the amino acid sequences encoded by cas gene clusters. Deletion of the gene coding uracil phosphoribosyl-transferase (upp) was achieved in five B. breve strains from both groups using this system. In addition, translational termination of uracil phosphoribosyl-transferase was successfully achieved in B. breve FJSWX38M7 by single-base substitution of the upp gene and insertion of three stop codons. The gene encoding linoleic acid isomerase (bbi) in B. breve, being a characteristic trait, was deleted after plasmid curing, which rendered it unable to convert linoleic acid into conjugated linoleic acid, demonstrating the feasibility of successive editing. This study expands the toolkit for gene manipulation in B. breve and provides a new approach toward functional genome editing and analysis of B. breve strains. | en |
dc.description.sponsorship | National Key Research and Development Program of China (2022YFA0912200); National Natural Science Foundation of China (32021005); 111 Project (BP0719028) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | e02074-23 | en |
dc.identifier.citation | Han, X., Chang, L., Chen, H., Zhao, J., Tian, F., Ross, R. P., Stanton, C., van Sinderen, D., Chen, W. and Yang, B. (2024) 'Harnessing the endogenous Type I-C CRISPR-Cas system for genome editing in Bifidobacterium breve', Applied and Environmental Microbiology, 90(3), e02074-23 (16pp). https://doi.org/10.1128/aem.02074-23 | en |
dc.identifier.doi | https://doi.org/10.1128/aem.02074-23 | en |
dc.identifier.eissn | 1098-5336 | en |
dc.identifier.endpage | 16 | en |
dc.identifier.issn | 0099-2240 | en |
dc.identifier.issued | 3 | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/15813 | |
dc.identifier.volume | 90 | en |
dc.language.iso | en | en |
dc.publisher | American Society for Microbiology | en |
dc.rights | © 2024, American Society for Microbiology. All Rights Reserved. | en |
dc.subject | Bifidobacterium breve | en |
dc.subject | CRISPR-Cas | en |
dc.subject | Type I-C | en |
dc.subject | Genome editing | en |
dc.title | Harnessing the endogenous Type I-C CRISPR-Cas system for genome editing in Bifidobacterium breve | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- han-et-al-2024-harnessing-the-endogenous-type-i-c-crispr-cas-system-for-genome-editing-in-bifidobacterium-breve.pdf
- Size:
- 6.75 MB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted Version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: